Tech giants are driving mixed trading action in late June 2026, with unexpected winners gaining ground as the broader market grapples with sector-wide weakness. On June 26, the Nasdaq and S&P 500 essentially treaded water, with the S&P 500 declining 0.10% and sentiment pressured by a delayed OpenAI IPO announcement—a significant headwind for investor enthusiasm. Despite the cautious mood in technology stocks, individual winners emerged dramatically: Moderna surged 14.90%, FactSet Research Systems jumped 8.90%, and ServiceNow gained 7.36%, showing that selective buying exists even as larger trends weigh on the sector.
The day’s decliners underscore the volatility within tech itself. ON Semiconductor plummeted 21.74%, Western Digital dropped 10.38%, and Teradyne fell 9.98%—all steep moves concentrated in chip and semiconductor equipment manufacturers. This divergence between winners and losers reveals a market sorting between sectors as investors recalibrate their positions around AI-related valuations and the delayed IPO creating a risk-off sentiment in high-growth names.
Table of Contents
- What’s Driving the Split Between Tech Gainers and Sellers?
- Semiconductor and Chip Equipment Face Deeper Pressure
- Asian Tech Shows Rebound Despite U.S. Weakness
- How Individual Investors Should Assess These Daily Swings
- The OpenAI IPO Delay as a Systemic Risk Signal
- Biotech and Software Giants Hold Ground
- What Tomorrow’s Trading May Reveal
What’s Driving the Split Between Tech Gainers and Sellers?
The tech sell-off traces directly to investor anxiety over AI valuations and the OpenAI IPO delay. That delay sent a ripple through the entire sector, cooling enthusiasm that had been supporting even mature hardware and chip manufacturers. When a marquee IPO gets postponed, it signals either market conditions aren’t ready or the company itself is reconsidering terms—either way, it shakes confidence in the broader AI narrative that has been propping up valuations.
Yet some companies bucked the trend. Moderna’s 14.90% surge came from biotech strength, not artificial intelligence—a reminder that sector rotation was underway on June 26. ServiceNow and FactSet both serve enterprise software customers managing traditional business operations, not pure AI plays, which insulated them from the worst of the sentiment shift. The market wasn’t indiscriminately selling tech; it was repricing specific exposure to AI and chip equipment risk.
Semiconductor and Chip Equipment Face Deeper Pressure
The semiconductor sector was the hardest hit, with losses deepening where companies sell equipment or chips used in AI infrastructure. ON Semiconductor’s 21.74% drop was the worst of the day’s major movers—a signal that investors were exiting positions in companies perceived as benefiting from AI capex buildouts. Western Digital’s 10.38% decline and Teradyne’s 9.98% fall reinforce this pattern. These aren’t failed companies; they’re companies whose stock prices had climbed on expectations that may now face delays or smaller near-term orders.
This is a critical limitation of momentum-driven rallies: when the narrative shifts, the unwinding can be sharp. Chip stocks had been among the best performers for months on the assumption that AI data centers would demand continuous semiconductor upgrades. The OpenAI IPO delay suggests that either AI capex spending will slow, or that key players want to reconsider their own public market timing. Either way, suppliers sit in a vulnerable position until clarity emerges on actual capex plans and timelines.
Asian Tech Shows Rebound Despite U.S. Weakness
Across the Pacific, South Korean semiconductor heavyweights posted notable gains on June 24, 2026. Samsung Electronics climbed 9%, while SK Hynix rose 4%—a meaningful divergence from U.S. chip weakness. This recovery suggests that Asian investors were either less spooked by the IPO delay or saw an opportunity in lower valuations after the earlier sell-off. The geographic split matters because it shows where capital is rotating. U.S.
technology equities were broadly weak (Nasdaq Composite down 0.43% to 25,476.64 on June 24), yet Korean chip makers attracted buying interest. This can signal that international investors view Asian semiconductor valuations as more reasonable than U.S. peers, or that they expect Samsung and SK Hynix to capture orders if U.S. chip companies face headwinds. For U.S. investors, it’s a reminder that individual stock performance often depends on global capital flows, not just domestic sentiment.
How Individual Investors Should Assess These Daily Swings
Large single-day moves like the ones seen on June 26 can tempt reactive trading, but they often obscure the underlying business fundamentals. Moderna’s 14.90% gain didn’t represent a sudden breakthrough in its biotech pipeline; it reflected sector money rotating from growth names into defensive healthcare. FactSet’s 8.90% jump may simply reflect its subscription-based software model being perceived as lower-risk than pure-play AI infrastructure exposure. For investors holding these stocks for longer periods, such volatility is noise rather than signal.
The tradeoff between chasing momentum and maintaining conviction is stark. A trader who bought Moderna at the open and sold at the close captured that 14.90% gain. An investor in ON Semiconductor who tried to catch the falling knife by buying on the 21.74% drop without understanding why chip equipment demand might slow could face further losses. The practical approach is to understand the fundamental drivers (in this case, AI capex uncertainty and IPO timing) rather than treating daily percentage moves as predictive of future performance.
The OpenAI IPO Delay as a Systemic Risk Signal
When one of the most anticipated IPOs gets postponed, it sends a shock through the entire AI ecosystem. Investors had built pricing models assuming OpenAI would reach public markets in mid-2026, validating AI infrastructure spending and signaling confidence in demand. A delay doesn’t necessarily mean the IPO is cancelled—it may simply mean the company or underwriters wanted more time or better conditions—but uncertainty itself is a risk.
This delay warned investors that even the most hyped IPOs can face headwinds, and if OpenAI is hesitating, how solid is the capex outlook for suppliers? That question led to the sharp selloff in semiconductor and chip equipment names. A limitation of this fear-based selling is that it may overcorrect: if OpenAI reschedules for Q3 or Q4 2026 and the capex narrative remains intact, the same stocks could rebound sharply. Investors caught off-guard by the volatility should recognize that IPO timing is often driven by legal, regulatory, and market-condition factors beyond the underlying business health.
Biotech and Software Giants Hold Ground
While semiconductors reeled, biotech and enterprise software showed relative strength. Moderna’s gain alongside broader healthcare market strength suggests money was moving defensively, away from cyclical hardware and into sectors with steadier revenue streams. ServiceNow’s 7.36% rise reflects the reality that software-as-a-service (SaaS) companies have more predictable, recurring revenue than chip makers whose orders are lumpy and dependent on capex cycles.
This divergence is important for portfolio construction. A diversified technology-heavy portfolio that includes both semiconductor suppliers and SaaS companies would have been cushioned: the 8.90% gain in FactSet and 7.36% rise in ServiceNow would have offset some of the damage from ON Semiconductor’s 21.74% collapse. For investors overweight in hardware or equipment, June 26 was a reminder that sector concentration matters, especially when sentiment shifts on a single narrative (in this case, AI capex timing).
What Tomorrow’s Trading May Reveal
June 26 was a one-day snapshot of a market recalibrating around AI risk and IPO timing. The Nasdaq Composite’s 0.43% decline and S&P 500’s 0.10% loss on June 24 showed the broader market wasn’t in panic mode, but was shedding exposure selectively. Investors will likely watch for any announcements from major chipmakers or infrastructure companies about demand outlook—guidance that could either confirm the sell-off’s caution or suggest it overreacted. The winners and losers of June 26 also highlight a key reality: “the market” is not monolithic.
While tech as a category faced headwinds, Moderna, FactSet, and ServiceNow found buyers. ON Semiconductor, Western Digital, and Teradyne found sellers. Both moves happened simultaneously, driven by the same macro uncertainty but with different conclusions about which businesses would thrive or struggle in the months ahead. The next weeks will test whether the market’s repricing proves prescient or excessive.
- —